Clinical Trial Update: Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sequential or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Chaosu Hu | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN